SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-08-001826
Filing Date
2008-11-10
Accepted
2008-11-10 16:44:50
Documents
4
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT avigen_10q.htm 10-Q 422728
2 CEO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit31-1.htm EX-31.1 5904
3 CFO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit31-2.htm EX-31.2 5761
4 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) AND SECTION 1350 exhibit32-1.htm EX-32.1 3768
  Complete submission text file 0001206774-08-001826.txt   439569
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28272 | Film No.: 081176328
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences